Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
EV/Core EBITDA

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 12.039.6951.0913.848.11

What is the latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE ?

The latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE is 12.03 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202412.03
Mar20239.69
Mar202251.09
Mar202113.84
Mar20208.11

How is EV/Core EBITDA of STRIDES PHARMA SCIENCE Trending?

Years EV/Core EBITDA % Change
Mar2024 12.03
24.15
Mar2023 9.69
-81.03
Mar2022 51.09
269.15
Mar2021 13.84
70.65
Mar2020 8.11 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare EV/Core EBITDA ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹6,364.6 Cr -6.4% -51.2% 22.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,361.0 Cr -1.4% 1.2% 46.9% Stock Analytics
DIVIS LABORATORIES ₹155,274.0 Cr -1.4% 1.8% 60% Stock Analytics
CIPLA ₹117,144.0 Cr -0.3% -3.3% 19.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,134.0 Cr 0.8% 1.8% 13.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,554.4 Cr -1.7% 1.2% 53.9% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-6.4%

-51.2%

22.7%

SENSEX

-1%

3.9%

16%


You may also like the below Video Courses